Showing results (191-200 of 206) with videos related to
Sort By:
Pageof 21
Neuron|September 7, 2018
Tau Protein Disrupts Nucleocytoplasmic Transport in Alzheimer's DiseaseBahareh Eftekharzadeh, J Gavin Daigle, Larisa E Kapinos, et al.Neurology|October 4, 2019
Prospective natural history study of <i>C9orf72</i> ALS clinical characteristics and biomarkersAlexander J Cammack, Nazem Atassi, Theodore Hyman, et al.Nature Neuroscience|March 22, 2016
C9ORF72 poly(GA) aggregates sequester and impair HR23 and nucleocytoplasmic transport proteinsYong-Jie Zhang, Tania F Gendron, Jonathan C Grima, et al.Nature Neuroscience|April 2, 2014
Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosisJanel O Johnson, Erik P Pioro, Ashley Boehringer, et al.Iscience|November 8, 2021
An integrated multi-omic analysis of iPSC-derived motor neurons from C9ORF72 ALS patients, Jonathan Li, Ryan G Lim, et al.Journal of Neurology, Neurosurgery, and Psychiatry|May 16, 2022
Effect of sodium phenylbutyrate/taurursodiol on tracheostomy/ventilation-free survival and hospitalisation in amyotrophic lateral sclerosis: long-term results from the CENTAUR trialSabrina Paganoni, Suzanne Hendrix, Samuel P Dickson, et al.Plos One|September 7, 2012
Creation of an open-access, mutation-defined fibroblast resource for neurological disease researchSelina Wray, Matthew Self, , et al.Nature Medicine|July 15, 2025
The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and agingFarhad Imam, Rowan Saloner, Jacob W Vogel, et al.The New England Journal of Medicine|September 3, 2020
Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral SclerosisSabrina Paganoni, Eric A Macklin, Suzanne Hendrix, et al.Muscle & Nerve|October 16, 2020
Long-term survival of participants in the CENTAUR trial of sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosisSabrina Paganoni, Suzanne Hendrix, Samuel P Dickson, et al.Pageof 21